Dr Reddy's Laboratories launches Nitroglycerin sublingual tablets in U.S. market
On 26 August 2016
Dr Reddy's Laboratories has launched Nitroglycerin sublingual tablets USP, 0.3 mg, 0.4 mg and 0.6 mg, a therapeutic equivalent generic version of Nitrostat sublingual tablets in the U.S. market on 26 August 2016, having been approved by the United States Food and Drug Administration.Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Aug 29 2016 | 1:29 PM IST